Brief: Samsung Pharmaceutical lowers conversion price of 27th series convertible bonds to 3,772 won/share
April 24 (Reuters) - Samsung Pharmaceutical Co Ltd
001360.KS :
* Says it lowered conversion price of 27th series
unregistered and unsecured private convertible bonds to 3,772
won/share from 4,123 won/share, effective April 24
Source text in Korean: https://goo.gl/gej57F
Further company coverage: 001360.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Samsung Pharm
See all newsBrief: Samsung Pharmaceutical Wins 33.5 Billion Won Order
Brief: Samsung Pharmaceutical Says Acquires Shares Worth 12.5 bln Won In True Life Insurance Bank
Brief: Samsung Pharmaceutical To Invest 15.3 Billion Won To Build New Manufacturing Line
Brief: Samsung Pharmaceutical To Sell 8 Bln Won Asset To Samsung Medicos
Brief: Samsung Pharmaceutical Plans 20 Bln Won Investment In S.Korea